Now Accepting Patients NBC News Producer Personal Journey – It’s all About Early Detection & Prevention – Hawaii First Alzheimer’s Prevention Trial – PrevenTRON now Accepting Patients PrevenTRON, Phase 3 Prevention Trial of Trontinemab in Cognitively Unimpaired Individuals at High…
Honolulu, October 2026 The neurologists, epileptologists and research team of Hawaii’s Comprehensive Epilepsy Center & Epilepsy Research Unit. The Hawaii Comprehensive Epilepsy Center and Epilepsy Research Unit have been awarded a new Phase 3 study investigating JZP926 (CBD oral solution,…
A Legacy of Service Dr. Kore Kai Liow Named 2026 Physician of the Year by the Hawaiʻi Medical Association A career defined by compassion, innovation, mentorship, and an unwavering commitment to the people of Hawaiʻi Award presented by Governor Josh…
Honolulu, September 2026 The neurologists, research staff and coordinators of the Hawaii Memory Disorders Center & Alzheimer’s Research Unit. Hawaii’s first Alzheimer’s prevention trial is now accepting patients. Hawaii Pacific Neuroscience has been selected as the Hawaii site for PrevenTRON,…
Honolulu, September 2026 Published in Epilepsy Research, Volume 228, 2026. A new study from researchers at Hawaii Pacific Neuroscience (HPN) and the University of Hawai‘i John A. Burns School of Medicine has been published in the journal Epilepsy Research. The…
Honolulu, July 2026 A University of Hawai‘i professor and Hawaii neurologist has been asked to serve on the Advisory Council of the International Society to Advance Alzheimer’s Research and Treatment (ISTAART), the professional society of the Alzheimer’s Association. The appointment…
Hawaii Memory Center & Alzheimer’s Research Unit to Present EEG Biomarker Research at the 2026 London AAIC Our team is proud to collaborate with Advanced Brain Monitoring to present new findings at the 2026 Alzheimer’s Association International Conference (AAIC) in…
Honolulu, May 2026 — The Hawaii Comprehensive Epilepsy Center & Epilepsy Research Unit has been awarded the FOCUS 2 study investigating RAP-219, an investigational modulator of AMPA receptors, for adult patients with focal seizures. RAP-219 is a first-in-class, selective negative…
Honolulu, June 2026 — The Hawaii Comprehensive Epilepsy Center & Epilepsy Research Unit has been awarded a study investigating JZP926 or Epidiolex for the treatment of Juvenile Myoclonic Epilepsy (JME). JME is the most common generalized epilepsy syndrome. Myoclonic jerks…
The team at Hawaii Comprehensive Epilepsy Center & Epilepsy Research Unit. Honolulu, June 2026 — The Hawaii Comprehensive Epilepsy Center & Epilepsy Research Unit has been awarded a study investigating BMB-101 for the treatment of Developmental and Epileptic Encephalopathies (DEEs).…
RECENT BLOGS
-
NBC News Producer Personal Journey – It’s all AboutEarly Detection & Prevention - Hawaii First Alzheimer’sPrevention Trial - PrevenTRON now Accepting Patients
-
2026 Hawaii Comprehensive Epilepsy Center & Epilepsy Research Unit Awarded Study to Investigate (JZP926 or Epidiolex) for the Treatment of Developmental and Epileptic Encephalopathy (DEE)
-
Dr. Kore Kai Liow Named 2026 Hawaii Physician of the Year | HPN
-
First Hawaii Alzheimer's Prevention Trial Now Accepting Patients
-
Epilepsy-Associated Labor Force Exclusion in a NHPI Multi-Ethnic Cohort
-
UH Professor & Hawaii Neurologist Joins ISTAART Council
-
HPN & Advanced Brain Monitoring Present EEG Biomarker Study at AAIC 2026
-
RAP-219 FOCUS 2 Focal Seizure Study | Hawaii Epilepsy
HPN Office Hours
Monday :
8AM - 5PM
Tuesday :
8AM - 5PM
Wednesday :
8AM - 5PM
Thursday :
8AM - 5PM
Friday :
8AM - 5PM
Saturday :
CLOSED
SUNDAY :
CLOSED